The treatment of eclampto dementia has been welcomed! Experimental gene therapy PR006.
-
Last Update: 2020-07-30
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
!----, a biotechnology company dedicated to gene therapy for neurodegenerative diseases, prevail today announced that the U.S. Patent and Trademark Office (USPTO) has issued a U.S. patent number 10689625 on June 23, 2020, involving PR0006's AAV vector.PR006 is An experimental gene therapy for Prevail to treat patients with erythema (FTD-GRN) with GRN mutations.PR006 is being developed as a potential one-time gene therapy for FTD-GRN, a progressive neurodegenerative disease caused by the GRN gene mutation, which reduces the production of granuelal genitor, a key protein for lysozymatic function, neuronal survival, and normal small glial cell activity.pre-granule protein deficiency can lead to lysozyme dysfunction, ineffective protein degradation and nerve inflammation, and ultimately to neurodegeneration and death. "FTD-GRN is a devastating disease and there are no treatment options that can improve the disease," said Dr. Asa Abeliovich,prevail s., CHIEF executive officer.March this year, Prevail announced positive results from the Phase I/II clinical trial for THE treatment of FTD-GRN, and the U.S. Food and Drug Administration (FDA) has awarded PR006 fast track eligibility..
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
